Wilmer Córdova-Calderón

Wilmer Córdova-Calderón

Auto-generated profile, based on publicly available information

Wilmer Córdova-Calderón

Asthma Allergy and Immunology Instituto Nacional de Salud del Niño – Breña Breña Lima Peru

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2020 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
DGDavid García-Gomero
David García-Gomero
MLMaría del Carmen López-Talledo
María del Carmen López-Talledo
CGCesar Alberto Galvan
Cesar Alberto Galvan
RMRicardo Muñoz-León
Ricardo Muñoz-León
EMEdgar Matos-Benavides
Edgar Matos-Benavides
WCWilmer Córdova-Calderón
Wilmer Córdova-Calderón
Con el objetivo de determinar el perfil de sensibilización a aeroalérgenos en pacientes pediátricos con asma y/o rinitis alérgica se realizó un estudio transversal en 411 pacientes usando una prueba cutánea de alergia. Se analizó la edad, sexo, nivel de IgE total y eosinófilos. La edad media fue de 8,1 ± 3,7 años y el 60,6% fueron varones. La media de los eosinófilos y el nivel de IgE total fue de 450,1 ± 377,3 células/mm3 y 861,7 ± 757,6 IU/mL, respectivamente. Los ácaros fueron los alérgenos sensibilizantes más frecuentes (79,8%) y el Dermatophagoides farinae (65,2%) fue el más común. La polisensibilización estuvo presente en el 76,2% de los pacientes. La sensibilización se evidenció en la mayoría de los pacientes con asma y/o rinitis alérgica y estuvo asociada con la edad, grupos etarios y nivel de IgE total.

29 August 2018 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
DGDavid García-Gomero
David García-Gomero
WCWilmer Córdova-Calderón
Wilmer Córdova-Calderón
JAJuan Aldave-Becerra
Juan Aldave-Becerra
Registro de pacientes con inmunodeficiencias primarias en los tres principales centros de referencia del Perú

26 April 2024 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
CGCesar Alberto Galvan
Cesar Alberto Galvan
CDCecilia Díaz‐Vásquez
Cecilia Díaz‐Vásquez
WCWilmer Córdova‐Calderón
Wilmer Córdova‐Calderón
JTJuan Gómez de la Torre
Juan Gómez de la Torre
EMEdgar Matos‐Benavides
Edgar Matos‐Benavides
CTCrhistian Toribio‐Dionicio
Crhistian Toribio‐Dionicio
Background: Cow's milk protein allergy (CMPA) remains relatively understudied in Latin America.Methods: In this observational study, we enrolled 64 patients with a median age of 3 months, of whom 60% were male. Patients included had a history of IgE‐mediated reactions with IgE sensitization or non‐IgE‐mediated reactions or symptoms following exposure to cow's milk. They underwent skin prick test, ImmunoCAP, fecal calprotectin (FC), and fecal eosinophil‐derived neurotoxin (EDN), in addition to double‐blinded placebo‐controlled oral food challenges (DBPCFC), with clinical evolution and tolerance acquisition observed over 1 year.Results: Malnutrition was present in 78.1% of patients, and 87.5% had a family history of atopy, with 51.6% receiving exclusive breastfeeding. Gastrointestinal manifestations were prevalent in 90.6% of patients, followed by dermatological manifestations (10.9%), with only 2 experiencing anaphylaxis. IgE‐mediated CMPA was observed in only six patients. In those with non‐IgE‐mediated CMPA, FC had a median of 284 mg/dL (IQR: 138.5–415.5), while EDN had a median of 508.5 mg/dL (IQR: 160.25–868). One year after diagnosis, median FC significantly decreased (p < 0.0001), and malnutrition prevalence reduced to 17.1%. Moreover, 81% of patients acquired tolerance following DBPCFC, with 52% utilizing nutritional replacement formulas at diagnosis. Notably, 94% of those extensively hydrolyzed casein‐based formulas achieved tolerance (p = 0.08).Conclusion: Our findings provide a foundational framework for future investigations into CMPA diagnosis, tolerance acquisition, and the utilization of hypoallergenic formulas tailored to the unique characteristics of our region.

3 December 2021 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
LVLiz Eliana Veramendi-Espinoza
Liz Eliana Veramendi-Espinoza
JZJessica Hanae Zafra-Tanaka
Jessica Hanae Zafra-Tanaka
CTCrhistian Toribio-Dionicio
Crhistian Toribio-Dionicio
MRMariella Rosalina Huaman Rivera
Mariella Rosalina Huaman Rivera
GPGabriela Pérez
Gabriela Pérez
WCWilmer Córdova-Calderón
Wilmer Córdova-Calderón
Objective To investigate the level of awareness of primary immunodeficiency diseases among physicians working at Instituto Nacional de Salud del Niño. Methods Cross-sectional study including pediatric residents and pediatricians working at the Instituto Nacional de Salud del Niño during the study period (2017-2019). Physicians working at the immunology unit and surgery departments were excluded. Three aspects of awareness of primary immunodeficiency diseases were investigated: education, general knowledge, and diagnostic suspicion and actions taken in the face of suspicion. Results [...] ABSTRACT Objective To investigate the level of awareness of primary immunodeficiency diseases among physicians working at Instituto Nacional de Salud del Niño. Methods Cross-sectional study including pediatric residents and pediatricians working at the Instituto Nacional de Salud del Niño during the study period (2017-2019). Physicians working at the immunology unit and surgery departments were excluded. Three aspects of awareness of primary immunodeficiency diseases were investigated: education, general knowledge, and diagnostic suspicion and actions taken in the face of suspicion. Results

1 June 2017 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
DMDaniel Mendoza-Quispe
Daniel Mendoza-Quispe
DGDavid García-Gomero
David García-Gomero
WCWilmer Córdova-Calderón
Wilmer Córdova-Calderón
Diagnóstico situacional de las inmunodeficiencias primarias: aproximación preliminar

30 January 2024
Verified
Preprint
Open access
PDF file
CGCesar Alberto Galvan
Cesar Alberto Galvan
CVCecilia Diaz Vasquez
Cecilia Diaz Vasquez
WCWilmer Córdova-Calderón
Wilmer Córdova-Calderón
JTJuan Gomez de la Torre
Juan Gomez de la Torre
EMEdgar Matos-Benavides
Edgar Matos-Benavides
Cow’s milk protein allergy (CMPA) in Latin America is little studied. We conducted a prospective study in 64 patients with a median age of 3 months, 39/64 (60.94%) were male, 23/64 (35.93%) had malnutrition, 56/64 (87.5%) had familiar atopy, 34/64 (51.56%) were receiving exclusive breastfeeding (EBF). The patients passed a medical evaluation by the specialist and underwent: Prick Test, ImmunoCAP, Fecal Calprotectin (FC) and fecal eosinophil derived neurotoxin (EDN), double-blind placebo control oral food challenges (DBPCFC) and were observed for one year regarding their clinical evolution and acquisition of tolerance. 58/64 (90.63%) had gastrointestinal manifestations, 7/64 (10.94%) had a dermatological manifestation, 2/64 (3.1%) had respiratory manifestations and 2/64 (3.1%) had anaphylaxis. 6/64 (9.38%) had an IgE - mediated CMPA. In patients with Non - IgE Mediated CMPA, fecal calprotectin was found to have a median of 284 mg/dL and an interquartile range (IQR) of 138.5 - 415.5. EDN had a median of 508.5 mg/dL with an IQR of 160.25 - 868. One year after diagnosis, the median FC decreased significantly with p < 0.0001. Malnutrition after one year was reduced to 17.18%. Likewise, 52/64 (81%) acquired tolerance after practicing DBPCFC on them. 33/64 (52%) used nutritional replacement formulas from the time of diagnosis, those who used Nutramigen LGG 15/16 (94%) acquired tolerance after practicing DBPCFC while 12/17 (71%) of those who used other formulas acquired tolerance (p. 0.08). Our findings are a good starting point for future studies that explore the diagnosis, acquisition of CMPA tolerance, and the use of hypoallergenic formulas with the particularities of our region.